Immunomodulation by cocaine and ketamine in postnatal rats

Toxicology

Volumn 188, Issue 1, 2003, Pages 101-114

  Rofael, Hany Z ^a   Turkall, Rita M ^a,b   Abdel Rahman, Mohamed S ^a  

^a RUTGERS NEW JERSEY MEDICAL SCHOOL   (United States)

^b UNIVERSITY OF MEDICINE AND DENTISTRY OF NEW JERSEY   (United States)

Author keywords

Cocaine; Corticosterone; Immunomodulation; Ketamine; Norcocaine; Sheep red blood cells; Th1 Th2

Indexed keywords

COCAINE; CORTICOSTERONE; GAMMA INTERFERON; IMMUNOGLOBULIN M ANTIBODY; INTERLEUKIN 10; KETAMINE; NORCOCAINE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ANTIBODY RESPONSE; ARTICLE; BODY WEIGHT; CELLULAR IMMUNITY; CIRCULATION; CONTROLLED STUDY; CORTICOSTERONE BLOOD LEVEL; DRUG ABUSE; HUMORAL IMMUNITY; IMMUNE SYSTEM; IMMUNOMODULATION; INHIBITION KINETICS; LACTATION; LEUKOCYTE COUNT; LONG TERM EXPOSURE; LYMPHOCYTE COUNT; MALE; METABOLISM; NEUROENDOCRINOLOGY; NEUTROPHILIA; NEWBORN; NONHUMAN; PERINATAL PERIOD; PREGNANCY; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; RAT; SHEEP ERYTHROCYTE; SIMULATION; SPLEEN WEIGHT;

ANIMALIA; OVIS ARIES;

EID: 0037718301     PISSN: 0300483X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0300-483X(03)00081-7     Document Type: Article

References (65)

1. Abdel-Rahman M.S., Ismail E. Teratogenic effect of ketamine and cocaine in CF-1 mice. Teratology. 61:2000;291-296.
2. Barat S., Turkall R. Effect of sub-chronic cocaine and lidocaine exposure on the lymphoid tissues in neonatal rats. Toxicol. Lett. 89:1996;201-206.
3. Bendersky M., Alessandri S., Gilbert P., Lewis M. Characteristics of pregnant substance abusers in two cities in the northeast. Am. J. Drug Alcohol Abuse. 22:1996;349-362.
4. Berney S. Characterization of glucocorticoid-induced change in lymphocyte circulation in the rat. Clin. Res. 22:1974;414A.
5. + lymphocytes. J. Immunol. 158:1997;5569-5595.
6. Bohn A., Forsyth C., Kerkvliet N., Frank A. Immunologic effects of cocaine in prenatally exposed rats and mice. Toxicol. Lett. 91:1997;47-55.
7. Bowman B., Vaughan S., Walker Q., Davis S., Little P., Scheffler N., Thomas B., Kuhn C. Effects of sex and gonadectomy on cocaine metabolism in the rat. J. Pharmacol. Exp. Ther. 290:1999;1316-1323.
8. Chasnoff I., Lewis D., Squires L. Cocaine intoxication in a breast-fed infant. Pediatrics. 80:1987;836-838.
9. Damianopoulos E., Carey R. Evidence for N-methyl-D-aspartate receptor mediation of cocaine induced corticosterone release and cocaine conditioned stimulant effects. Behav. Brain Res. 68:1995;219-228.
10. Daynes R., Araneo B. Contrasting effects of glucocorticoids on the capacity of T cells to produce the growth factor interleukin 2 and interleukin 4. Eur. J. Immunol. 19:1989;2319-2325.
11. + lymphocytes by inhibiting IL-12 production. J. Immunol. 160:1998;2231-2237.
12. Devi B., Chan A. Cocaine-induced peroxidative stress in rat liver: antioxidant enzymes and mitochondria. J. Pharmacol. Exp. Ther. 279:1996;359-366.
13. Dickson P., Lind A., Studts P., Nipper H., Makoid M., Therkildsen D. The routine analysis of breast milk for drugs of abuse in a clinical toxicology laboratory. J. Forensic Sci. 39:1994;207-214.
14. Dietert R., Etzel R., Chen D., Halonen M., Holladay S., Jarabek A., Landreth K., Peden D., Pinkerton K., Smialowicz R., Zoetis T. Workshop to identify critical windows of exposure for children's health: immune and respiratory systems work group summary. Environ. Health Perspect. Suppl. 108:2000;483-490.
15. Di Francesco P., Falchetti R., Gaziano R., Lanzilli G., Belogi L., Ravagnan G., Garaci E. Differential effects of short-term or prolonged cocaine exposure on peripheral blood cells in mice. Life Sci. 54:1994;2015-2020.
16. Dillmann J. Ketamine abuse - a new edge. Todays Surg. Nurs. 20:1998;37-39.
17. Dorfman R., Dorfman A. The relative thymolytic activities of corticoids using the overiectomized-adrenalectomized mouse. Endocrinology. 69:1961;283-291.
18. Figliomeni M., Turkall R. Developmental immunotoxicity of cocaine and ethanol in postnatal Lewis rats. Immunopharmacology. 36:1997;41-48.
19. Fleshner M., Deak T., Nguyen K., Watkins L., Maier S. Endogenous glucocorticoids play a positive regulatory role in the anti-keyhole limpet hemocyanin in vivo antibody response. J. Immunol. 166:2001;3813-3819.
20. Gomby, D., Shiono, P., 1991. Estimating the number of substance-exposed infants. Future Child J. 1, 17-25.
21. Gow P., Ghabrial H., Smallwood R., Richard A., Morgan D., Ching M. Neonatal hepatic drug elimination. Pharmacol. Toxicol. 88:2001;3-15.
22. Havas H., Dellaria M., Schiffman G., Geller E., Adler M. Effect of cocaine on the immune response and host resistance in BALB/c mice. Int. Arch. Allergy Appl. Immunol. 83:1987;377-383.
23. Hill G., Anderson J., Lyden E. Ketamine inhibits the proinflammatory cytokine-induced reduction of cardiac intracellular cAMP accumulation. Anesth. Analg. 87:1998;1015-1019.
24. Huber J., Darling S., Park K., Soliman K. The role of NMDA receptors in neonatal cocaine-induced neurotoxicity. Pharmacol. Biochem. Behav. 69:2001;451-459.
25. Inomata T., Nakamura T. Influence of adrenalectomy on the development of the neonatal thymus in rats. Biol. Neonate. 55:1989;238-243.
26. Jaffe H. The influence of the suprarenal gland on the thymus - regeneration of the thymus following double suprarenalectomy in the rat. J. Exp. Med. 40:1924;325-343.
27. Jansen K., Darracot-Cankovic R. The nonmedical use of ketamine. II. A review of problem use and dependence. J. Psychoactive Drugs. 33:2001;151-158.
28. Jeong T., Matulka R., Jordan S., Yang K., Holsapple M. Role of metabolism in cocaine-induced immunosuppression in splenocyte cultures from B6C3F1 female mice. Immunopharmacology. 29:1995;37-46.
29. Jeong T., Jordan S., Matulka R., Stanulis E., Kaminski E., Holsapple M. Role of metabolism by esterase and cytochrome P-450 in cocaine-induced suppression of the antibody response. J. Pharmacol. Exp. Ther. 272:1995;407-416.
30. Jeong T., Jordan S., Matulka R., Stanulis E., Park S., Holsapple M. Immunosuppression induced by acute exposure to cocaine is dependent on metabolism by cytochrome P-450. J. Pharmcol. Exp. Ther. 276:1996;1257-1265.
31. Johnson C., Williams W., Copeland M., DeVito M., Smialowicz R. Sensitivity of the SRBC PFC assay versus ELISA for detection of immunosuppression by TCDD and TCDD-like congeners. Toxicology. 156:2000;1-11.
32. Knisely J., Spear E., Green D., Christmas J., Schnoll S. Substance abuse patterns in pregnant women. NIDA Res. Monogr. 108:1991;280-281.
33. Kump D., Matulka R., Burton G., Jordan S., Holsapple M. Alternations in splenocyte and thymocyte subpopulations in B6C3F1 mice exposed to cocaine plus diazinon. J. Pharmacol. Exp. Ther. 277:1996;1477-1485.
34. Kump D., Stanulis E., Holsapple M., Conrad D., Rosecrans J. Cocaine-induced release of corticosterone mediates differential effects on T-helper 1 and T-helper 2 cell responses. Adv. Exp. Med. Biol. 437:1998;189-198.
35. Ladics G., Smith C., Heaps K., Elliott G., Slone T., Loveless S. Possible incorporation of an immunotoxicological functional assay for assessing humoral immunity for hazard identification purposes in rats on standard toxicology study. Toxicology. 96:1995;225-238.
36. Ladics G., Smith C., Elliott G., Slone T., Loveless S. Further evaluation of the incorporation of an immunotoxicological functional assay for assessing humoral immunity for hazard identification purposes in rats in a standard toxicology study. Toxicology. 126:1997;137-152.
37. Luster M., Munson A., Thomas P., Holsapple M., Fenters J., White K. Jr., Lauer L., Germolec D., Rosenthal G., Dean J. Development of attesting battery to assess chemical-induced immunotoxicity: National Toxicology Program's guidelines for immunotoxicity evaluation in mice. Fundam. Appl. Toxicol. 10:1988;2-19.
38. Malmberg K., Arulampalam V., Ichihara F., Petersson M., Seki K., Andersson T., Lenkei R., Masucci G., Pettersson S., Kiessling R. Inhibition of activated/memory (CD45RO(+)) T cells by oxidative stress associated with block of NF-kappa B activation. J. Immunol. 167:2001;2595-2601.
39. Marietta M., Vore M., Way W., Trevor A. Characterization of ketamine induction of hepatic microsomal drug metabolism. Biochem. Pharmacol. 26:1977;2451-2453.
40. Mashaly M., Trout J., Hendricks G. III, Al-Dokhi L., Gehad A. The role of neuroendocrine immune interactions in the initiation of humoral immunity in chickens. Domest. Anim. Endocrinol. 15:1998;409-422.
41. Matulka, R., Smialowicz, R., 2002. Identification of the age at which immunotoxicological parameters can be evaluated in rats. Toxicologist 66, 1169.
42. Matulka R., Jordan S., Stanulis E., Holsapple M. Evaluation of sex- and strain-dependency of cocaine-induced immunosuppression in B6C3F1 and DBA/2 mice. J. Pharmacol. Exp. Ther. 279:1996;12-17.
43. McGhee J., Michalek S., Ghanta V. Rat immunoglobulins in serum and secretions: purification of rat IgM, IgA and IgG and their quantitation in serum, colostrum, milk and saliva. Immunochemistry. 12:1975;817-823.
44. Moynihan J., Karp J., Cohen N., Cocke R. Alterations in interleukin-4 and antibody production following pheromone exposure: role of glucocorticoids. J. Neuroimmunol. 54:1994;51-58.
45. National Institute on Drug Abuse, 1992. National Household Survey on Drug Abuse: Population Estimates, 1992. US Department of Health and Human Services, Rockville, MD, p. 31.
46. Ou D., Shen M., Luo Y. Effects of cocaine on the immune system of balb/c mice. Clin. Immunol. Immunopathol. 52:1989;305-312.
47. Oye I., Froynes W., Gloersen G., Nafstad I. Altered behavior in the progeny of rats exposed to ketamine, an N-methyl-D-aspartate receptor blocker. Pharmacol. Toxicol. 73:1993;240-242.
48. + T cells in vitro. J. Immunol. 156:1996;2406-2412.
49. Rofael H., Abdel-Rahman M.S. The role of ketamine on plasma cocaine pharmacokinetics in rat. Toxicol. Lett. 129:2002;167-176.
50. Rofael H., Abdel-Rahman M.S. Development and validation of a high-performance liquid chromatography method for the determination of cocaine, its metabolites and ketamine. J. Appl. Toxicol. 22:2002;123-128.
51. Roytblat L., Talmor D., Rachinsky M., Greemberg L., Pekar A., Appelbaum A., Gurman G., Shapira Y., Duvdenani A. Ketamine attenuates the interleukin-6 response after cardiopulmonary bypass. Anesth. Analg. 87:1998;266-271.
52. Selgrade M., Lawrence D., Ullrich S., Gilmour M., Schuyler M., Kimber I. Modulation of T-helper cell populations: potential mechanisms of respiratory hypersensitivity and immune suppression. TAAP. 145:1997;218-229.
53. Smialowicz R., Williams W., Copeland C., Harris M., Overstreet D., Davis B., Chapin R. The effects of perinatal/juvenile heptachlor exposure on adult immune and reproductive system function in rats. Toxicol. Sci. 61:2001;164-175.
54. Sobrian S., Burton L., Robinson N., Ashe W., James H., Stokes D., Turner L. Neurobehavioral and immunological effects of prenatal cocaine exposure in rat. Pharmacol. Biochem. Behav. 35:1989;617-629.
55. Stanulis E., Matulka R., Jordan J., Rosecrans J., Holsapple M. Role of corticosterone in enhancement of the antibody response after acute cocaine administration. Pharmacol. Exp. Ther. 280:1997;284-291.
56. Stanulis E., Jordan S., Rosecrans J., Holsapple M. Disruption of Th1/Th2 cytokine balance by cocaine is mediated by corticosterone. Immunopharmacology. 37:1997;25-33.
57. Takenaka I., Ogata M., Koga K., Matsumoto T., Shigematsu A. Ketamine suppresses endotoxin-induced tumor necrosis factor alpha production in mice. Anesthesiology. 80:1994;402-408.
58. Temple L., Kawabata T., Munson A., White K. Jr. Comparison of ELISA and plaque-forming cell assays for measuring the humoral immune response to SRBC in rats and mice treated with benzo[a]pyrene or cyclophosphamide. Fundam. Appl. Toxicol. 21:1993;412-419.
59. Temple L., Butterworth L., Kawabata T., Munson A., White K. Jr. ELISA to measure SRBC-specific IgM: methods and data evaluation. Burleson G., Dean J., Munson A. Methods in Immunotoxicology. 1:1995;137-157 Wiley/Liss, New York.
60. Torres G., Rivier C. Differential effects of intermittent or continuous exposure to cocaine on the hypothalamic-pituitary-adrenal axis and c-fos expression. Brain Res. 571:1992;204-211.
61. Torres G., Rivier C., Weiss F. A ketamine mixture anesthetic inhibits neuroendocrine and behavioral consequences of cocaine administration. Brain Res. 656:1994;33-42.
62. Tuchinda M., Newcomb R., DeVald B. Effect of prednisone treatment on the human immune response to keyhole limpet hemocyanin. Int. Arch. Allergy Appl. Immunol. 42:1972;533-544.
63. Vandebriel R., Meredith C., Scott M., Van Dijk M., Van Loveren H. Interleukin-10 is an unequivocal Th2 parameter in the rat, whereas interleukin-4 is not. Scand. J. Immunol. 52:2000;519-524.
64. Watzl B., Watson R. Immunomodulation by cocaine - a neuroendocrine mediated response. Life Sci. 46:1990;1319-1329.
65. Wiggins R., Rolsten C., Ruiz B., Davis C. Pharmacokinetics of cocaine: basic studies of route, dosage, pregnancy and lactation. Neurotoxicology. 10:1989;367-382.